Epiquin Related Published Studies
Well-designed clinical trials related to Epiquin (Hydroquinone / Retinol)
Comparative evaluation of beneficiary effects of priming agents (2% hydroquinone and 0.025% retinoic acid) in the treatment of melasma with glycolic acid peels. [2008.08]
A comparison of triple combination cream and hydroquinone 4% cream for the treatment of moderate to severe facial melasma. [2007.03]
Cost-effectiveness of a fixed combination of hydroquinone/tretinoin/fluocinolone cream compared with hydroquinone alone in the treatment of melasma. [2007.02]
Novel approach to the treatment of hyperpigmented photodamaged skin: 4% hydroquinone/0.3% retinol versus tretinoin 0.05% emollient cream. [2005.07]
Mequinol 2%/tretinoin 0.01% solution: an effective and safe alternative to hydroquinone 3% in the treatment of solar lentigines. [2004.11]
Efficacy of hydroquinone (2%) versus tretinoin (0.025%) as adjunct topical agents for chemical peeling in patients of melasma. [2004.03]
Well-designed clinical trials possibly related to Epiquin (Hydroquinone / Retinol)
A large 12-month extension study of an 8-week trial to evaluate the safety and efficacy of triple combination (TC) cream in melasma patients previously treated with TC cream or one of its dyads. [2005.09]
Efficacy and safety of a new triple-combination agent for the treatment of facial melasma. [2003.07]
Effect of pretreatment on the incidence of hyperpigmentation following cutaneous CO2 laser resurfacing. [1999.01]
Glycolic acid peels for postinflammatory hyperpigmentation in black patients. A comparative study. [1997.03]
Other research related to Epiquin (Hydroquinone / Retinol)
An open-label study of the efficacy and tolerability of microencapsulated hydroquinone 4% and retinol 0.15% with antioxidants for the treatment of hyperpigmentation. [2008.04]
Combined therapy using Q-switched ruby laser and bleaching treatment with tretinoin and hydroquinone for periorbital skin hyperpigmentation in Asians. [2008.01]
An efficacy study of 3 commercially available hydroquinone 4% treatments for melasma. [2007.12]
A clinical trial of topical bleaching treatment with nanoscale tretinoin particles and hydroquinone for hyperpigmented skin lesions. [2007.08]
Sun protection strength of a hydroquinone 4%/retinol 0.3% preparation containing sunscreens. [2006.04]
Hydroquinone 4%, tretinoin 0.05%, fluocinolone acetonide 0.01%: a safe and efficacious 12-month treatment for melasma. [2005.01]
A microsponge formulation of hydroquinone 4% and retinol 0.15% in the treatment of melasma and postinflammatory hyperpigmentation. [2004.12]
Combined therapy using Q-switched ruby laser and bleaching treatment with tretinoin and hydroquinone for acquired dermal melanocytosis. [2003.10]
Cosmetic color improvement of the nipple-areola complex by optimal use of tretinoin and hydroquinone. [2002.12]
Nail staining from hydroquinone cream. [2000.11]
Intermittent therapy for melasma in Asian patients with combined topical agents (retinoic acid, hydroquinone and hydrocortisone): clinical and histological studies. [1998.09]
Other possibly related research studies
Hyperpigmentation: an overview of the common afflictions. [2004.10]
Improved quality of life with effective treatment of facial melasma: the pigment trial. [2004.07]
Management of dyschromias in ethnic skin. [2004]
Rationale for the use of topical corticosteroids in melasma. [2004.03]
Lustra, Lustra-AF and Alustra. [2003.06]
Clinical trial of bleaching treatment with 10% all-trans retinol gel. [2003.02]
The combination of glycolic acid peels with a topical regimen in the treatment of melasma in dark-skinned patients: a comparative study. [2002.09]
Exogenous ochronosis. An update on clinical features, causative agents and treatment options. [2001]
Usefulness of a narrow-band reflectance spectrophotometer in evaluating effects of depigmenting treatment. [2001.03]
Experience with a strong bleaching treatment for skin hyperpigmentation in Orientals. [2000.03]
Melasma. [1999]
A new bleaching protocol for hyperpigmented skin lesions with a high concentration of all-trans retinoic acid aqueous gel. [1999.07]
Topical agents used in association with cosmetic surgery. [1999.06]
Solar-induced postinflammatory hyperpigmentation after laser hair removal. [1999.02]
Ultrapulse carbon dioxide laser with CPG scanner for full-face resurfacing for rhytids, photoaging, and acne scars. [1997.06]
Treatment of melasma with Jessner's solution versus glycolic acid: a comparison of clinical efficacy and evaluation of the predictive ability of Wood's light examination. [1997.04]
Melanin hyperpigmentation of skin: melasma, topical treatment with azelaic acid, and other therapies. [1996.01]
Sensitization of mice to paraphenylenediamine and structurally-related compounds: adjuvant effects of vitamin A supplementation. [1995.12]
Melasma. Etiologic and therapeutic considerations. [1995.12]
Organotropic formation and disappearance of 8-hydroxydeoxyguanosine in the kidney of Sprague-Dawley rats exposed to adriamycin and KBrO3. [1993.11.01]
UVB-induced pigmentation in hairless mice as an in vivo assay for topical skin-depigmenting activity. [1989]
Repeated treatment protocols for melasma and acquired dermal melanocytosis. [2006.03]
Community-based trial of a triple-combination agent for the treatment of facial melasma. [2006.03]
The treatment of melasma: a review of clinical trials. [2006.12]
Retinoid therapy of pigmentary disorders. [2006.09]
Postinflammatory hyperpigmentation: evolving combination treatment strategies. [2006.08]
New and experimental treatments of cloasma and other hypermelanoses. [2007.07]
Therapeutical approaches in melasma. [2007.07]
Validation of a melasma quality of life questionnaire for Brazilian Portuguese language: the MelasQoL-BP study and improvement of QoL of melasma patients after triple combination therapy. [2006.12]
Ethnic considerations in the treatment of Hispanic and Latin-American patients with hyperpigmentation. [2006.12]
Complementary effects of topical antiaging treatments in conjunction with aesthetic procedures. [2008.02]
|
